跳至主要内容
临床试验/NCT01111422
NCT01111422Unknown4 期

A Randomized Prospective Trial of N-acetyl Cystein in Patients With Peritoneal Dialysis

Ewha Womans University1 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2010年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
66
试验地点
1
主要终点
Peritoneal membrane function

研究概览

简要总结

Peritoneal fibrosis is one of the major causes of technical failure in patients on peritoneal dialysis (PD) for long period of time. Although the exact mechanisms of peritoneal damage during PD still remain unclear, generation of reactive oxygen species may be responsible for progressive membrane dysfunction. N-acetylcysteine (NAC)is a powerful antioxidant shown to protect peritoneal fibrosis in peritoneal dialysis animal model. In this study the researchers investigated the hypothesis that NAC protect peritoneal membrane damage.

详细描述

N-Acetylcysteine (NAC) is known to be relatively safe and beneficial in peritoneal dialysis patient at a dose of 1200 mg per day. Patients will be randomly assigned to NAC and control group and prescribed according to the protocol. At 2 and 6 month, Peritoneal equilibrium test (PET) will be performed with blood sampling.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Maintenance peritoneal dialysis at least 3 months
  • Patients who are able and willing to understand, sign and date an informed consent document, and authorize access to protected health information

排除标准

  • Episode of peritonitis at least 3 months
  • Episodes of admission due to other disease at lease 3 months
  • Liver disease
  • Allergic history with N-acetylcysteine

研究组 & 干预措施

N-acetylcysteine

Experimental

N-acetylcysteine in stable peritoneal dialysis patients

干预措施: N-acetylcysteine (Drug)

结局指标

主要结局

Peritoneal membrane function

时间窗: 6 months

Changes in peritoneal membrane function (Δ D/Pcreatinine, ΔD/Purea) with peritoneal equilibrium test

次要结局

  • Oxydative stress status(6 months)
  • Mesothelial cell transformation (Epithelial to Mesenchymal Transition)(6 month)
  • Residual renal function(6 month)
  • Peritoneal membrane function(2 months)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验